Development of White Matter Hyperintensity Is Preceded by Reduced Cerebrovascular Reactivity

Annals of Neurology

Volumn 80, Issue 2, 2016, Pages 277-285

  Sam, Kevin ^a,b   Crawley, Adrian P ^a,b   Conklin, John ^b   Poublanc, Julien ^b   Sobczyk, Olivia ^a,b   Mandell, Daniel M ^a,b   Venkatraghavan, Lakshmikumar ^b   Duffin, James ^a,b   Fisher, Joseph A ^a,b   Black, Sandra E ^a,c   Mikulis, David J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN FUNCTION; CARBON DIOXIDE TENSION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FOLLOW UP; FRACTIONAL ANISOTROPY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; RELAXATION TIME; WHITE MATTER; WHITE MATTER HYPERINTENSITY;

EID: 84981276289     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24712     Document Type: Article

References (50)

1. Hachinski VC, Potter P, Merskey H. Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci 1986;13(4 suppl):533–534.
2. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–838.
3. Verdelho A, Madureira S, Moleiro C, et al. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010;75:160–167.
4. Schmidt R, Schmidt H, Kapeller P, et al. The natural course of MRI white matter hyperintensities. J Neurol Sci 2002;203–204:253–257.
5. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000;14:224–232.
6. Malmstrom TK, Morley JE. The frail brain. J Am Med Dir Assoc 2013;14:453–455.
7. Whitman GT, Tang Y, Lin A, Baloh RW. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001;57:990–994.
8. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70:9–14.
9. Launer LJ, Berger K, Breteler MM, et al. Regional variability in the prevalence of cerebral white matter lesions: an MRI study in 9 European countries (CASCADE). Neuroepidemiology 2006;26:23–29.
10. Sobczyk O, Battisti-Charbonney A, Fierstra J, et al. A conceptual model for CO(2)-induced redistribution of cerebral blood flow with experimental confirmation using BOLD MRI. Neuroimage 2014;92:56–68.
11. Spano VR, Mandell DM, Poublanc J, et al. CO2 blood oxygen level-dependent MR mapping of cerebrovascular reserve in a clinical population: safety, tolerability, and technical feasibility. Radiology 2013;266:592–598.
12. Uh J, Yezhuvath U, Cheng Y, Lu H. In vivo vascular hallmarks of diffuse leukoaraiosis. J Magn Reson Imaging 2010;32:184–190.
13. Mandell DM, Han JS, Poublanc J, et al. Selective reduction of blood flow to white matter during hypercapnia corresponds with leukoaraiosis. Stroke 2008;39:1993–1998.
14. Sachdev P, Wen W, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 2007;68:214–222.
15. Conklin J, Fierstra J, Crawley AP, et al. Impaired cerebrovascular reactivity with steal phenomenon is associated with increased diffusion in white matter of patients with Moyamoya disease. Stroke 2010;41:1610–1616.
16. Conklin J, Fierstra J, Crawley AP, et al. Mapping white matter diffusion and cerebrovascular reactivity in carotid occlusive disease. Neurology 2011;77:431–438.
17. Conklin J, Silver FL, Mikulis DJ, Mandell DM. Are acute infarcts the cause of leukoaraiosis. Brain mapping for 16 consecutive weeks. Ann Neurol 2014;76:899–904.
18. de Groot M, Verhaaren BF, de Boer R, et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke 2013;44:1037–1042.
19. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–356.
20. Kisilevsky M, Hudson C, Mardimae A, et al. Concentration-dependent vasoconstrictive effect of hyperoxia on hypercarbia-dilated retinal arterioles. Microvasc Res 2008;75:263–268.
21. Ito S, Mardimae A, Han J, et al. Non-invasive prospective targeting of arterial P(CO2) in subjects at rest. J Physiol 2008;586(pt 15):3675–3682.
22. Fierstra J, Sobczyk O, Battisti-Charbonney A, et al. Measuring cerebrovascular reactivity: what stimulus to use? J Physiol 2013;591(pt 23):5809–5821.
23. Slessarev M, Han J, Mardimae A, et al. Prospective targeting and control of end-tidal CO2 and O2 concentrations. J Physiol 2007;581(pt 3):1207–1219.
24. Fisher JA, Iscoe S, Duffin J. Sequential gas delivery provides precise control of alveolar gas exchange. Respir Physiol Neurobiol 2016;225:60–69.
25. Vesely A, Sasano H, Volgyesi G, et al. MRI mapping of cerebrovascular reactivity using square wave changes in end-tidal PCO2. Magn Reson Med 2001;45:1011–1013.
26. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162–173.
27. Miller AJ, Joseph PM. The use of power images to perform quantitative analysis on low SNR MR images. Magn Reson Imaging 1993;11:1051–1056.
28. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208–S219.
29. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825–841.
30. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–155.
31. Ramirez J, Scott CJ, McNeely AA, et al. Lesion Explorer: a video-guided, standardized protocol for accurate and reliable MRI-derived volumetrics in Alzheimer's disease and normal elderly. J Vis Exp 2014(86).
32. Ramirez J, Gibson E, Quddus A, et al. Lesion Explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. Neuroimage 2011;54:963–973.
33. Maillard P, Carmichael O, Harvey D, et al. FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR Am J Neuroradiol 2013;34:54–61.
34. Haughton VM, Yetkin FZ, Rao SM, et al. Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med 1992;26:71–78.
35. Armspach JP, Gounot D, Rumbach L, Chambron J. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Imaging 1991;9:107–113.
36. Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004;35:2598–2603.
37. Ihara M, Tomimoto H. Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J Aging Res 2011;2011:978761.
38. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res 1998;792:105–113.
39. Farkas E, Donka G, de Vos RA, et al. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol 2004;108:57–64.
40. Hamann GF, Okada Y, Fitridge R, del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995;26:2120–2126.
41. Akiguchi I, Tomimoto H, Suenaga T, et al. Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study. Acta Neuropathol 1998;95:78–84.
42. Huang YH, Zhang WW, Lin L, et al. Could changes in arterioles impede the perivascular drainage of interstitial fluid from the cerebral white matter in leukoaraiosis? Neuropathol Appl Neurobiol 2010;36:237–247.
43. Munoz Maniega S, Chappell FM, Valdes Hernandez MC, et al. Integrity of normal-appearing white matter: influence of age, visible lesion burden and hypertension in patients with small-vessel disease. J Cereb Blood Flow Metab (in press).
44. Xiong YY, Mok V. Age-related white matter changes. J Aging Res 2011;2011:617927.
45. Knottnerus IL, Ten Cate H, Lodder J, et al. Endothelial dysfunction in lacunar stroke: a systematic review. Cerebrovasc Dis 2009;27:519–526.
46. Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 2010;81:192–197.
47. Taylor WD, MacFall JR, Provenzale JM, et al. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors. AJR Am J Roentgenol 2003;181:571–576.
48. Schmidt R, Petrovic K, Ropele S, et al. Progression of leukoaraiosis and cognition. Stroke 2007;38:2619–2625.
49. Mandell DM, Han JS, Poublanc J, et al. Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Stroke 2008;39:2021–2028.
50. Fisher JA. The CO2 stimulus for cerebrovascular reactivity: fixing inspired concentrations vs. targeting end-tidal partial pressures. J Cereb Blood Flow Metab 2016;36:1004–1011.